MACI Treatment

Vericel Corporation is a leading biotechnology company focused on developing innovative cell therapy products for patients with serious diseases and conditions. One of their flagship products, MACI®, is an advanced autologous cellularized scaffold designed specifically for the repair of full-thickness cartilage defects in the knee. This revolutionary treatment utilizes a patient's own cultured chondrocytes on a porcine collagen membrane, offering a personalized solution for those suffering from cartilage damage.

Vericel places a strong emphasis on clinical education and patient resources, ensuring that both healthcare professionals and patients can make informed decisions throughout the treatment process. Their offerings also include comprehensive information on surgical procedures, rehabilitation techniques, and practice resources aimed at enhancing patient recovery and outcomes. With a commitment to advancing cartilage repair technology, Vericel continues to elevate the standards of care for orthopedic injuries, providing patients with a pathway back to active lifestyles.